NCT01293461View on ClinicalTrials.gov

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

October 31, 2012

Conditions

Type 1 DiabetesDiabetes MellitusPeripheral Diabetic Neuropathy

Interventions

DRUG

CBX129801

Subcutaneous injection

DRUG

Placebo

Subcutaneous injection

Trial Locations (8)

Unknown

Escondido

Tustin

Walnut Creek

Aurora

Butte

San Antonio

Olympia

Renton

Sponsors

Lead Sponsor

Cebix Incorporated

All Listed Sponsors

lead

Cebix Incorporated

INDUSTRY